Showing results (101-110 of 129) with videos related to
Sort By:
Pageof 13
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 29, 2020
Association of Known Melanoma Risk Factors with Primary Melanoma of the Scalp and NeckRenee P Wood, Jane S Heyworth, Nina S McCarthy, et al.The Lancet. Oncology|July 1, 2024
Imaging with [89Zr]Zr-DFO-SC16.56 anti-DLL3 antibody in patients with high-grade neuroendocrine tumours of the lung and prostate: a phase 1/2, first-in-human trialSalomon Tendler, Mark P Dunphy, Matthew Agee, et al.Medrxiv : the Preprint Server for Health Sciences|January 23, 2024
First-in-human imaging with [89Zr]Zr-DFO-SC16.56 anti-DLL3 antibody in patients with high-grade neuroendocrine tumors of the lung and prostateSalomon Tendler, Mark P Dunphy, Matthew Agee, et al.Med (New York, N.Y.)|September 15, 2022
Sex differences in brain tumor glutamine metabolism reveal sex-specific vulnerabilities to treatmentJasmin Sponagel, Jill K Jones, Cheryl Frankfater, et al.The Lancet. Oncology|May 18, 2013
Surrogate endpoints for overall survival in chemotherapy and radiotherapy trials in operable and locally advanced lung cancer: a re-analysis of meta-analyses of individual patients' dataAudrey Mauguen, Jean-Pierre Pignon, Sarah Burdett, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 18, 2012
Impact of systematic EGFR and KRAS mutation evaluation on progression-free survival and overall survival in patients with advanced non-small-cell lung cancer treated by erlotinib in a French prospective cohort (ERMETIC project--part 2)Jacques Cadranel, Audrey Mauguen, Michele Faller, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 6, 2024
Pediatric Leukemia Roadmaps Are a Guide for Positive Metastatic Bone Sarcoma TrialsDamon R Reed, Asmin Tulpule, Jonathan Metts, et al.Neuro-Oncology Advances|January 4, 2021
Preclinical and first-in-human-brain-cancer applications of [18F]poly (ADP-ribose) polymerase inhibitor PET/MRRobert J Young, Paula Demétrio De Souza França, Giacomo Pirovano, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 4, 2012
Hyperfractionated or accelerated radiotherapy in lung cancer: an individual patient data meta-analysisAudrey Mauguen, Cécile Le Péchoux, Michele I Saunders, et al.Molecular Cancer Therapeutics|July 5, 2021
Phase 0 Clinical Trial of Everolimus in Patients with Vestibular Schwannoma or MeningiomaMatthias A Karajannis, Audrey Mauguen, Ekrem Maloku, et al.Pageof 13